Arena Pharmaceuticals is a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs for weight management, cardiovascular disease, inflammation and other disorders. The company’s internally discovered drug, BELVIQ (lorcaserin HCI), was approved by the U.S. FDA in June 2012 and is under review for regulatory approval in other jurisdictions. The company’s U.S. operations are located in San Diego, Calif., and its international operations – including its commercial manufacturing facility – are located in Zofingen, Switzerland. For more information, visit the company’s Web site at www.arenapharm.com.

The BIO CEO & Investor Conference is the largest investor conference focused on established and emerging publicly traded biotech companies. Each year the annual event provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry. For more information on Biotechnology Industry Organization (BIO), visit www.bio.org.

Let us hear your thoughts below: